Vanguard Capital Management Discloses 6.48% Stake in Eli Lilly & Co (LLY)

On May 1, 2026, Vanguard Capital Management LLC filed a Schedule 13G with the SEC, reporting a significant new ownership position in Eli Lilly & Co (LLY). As of the event date of March 31, 2026, the firm reported beneficial ownership of 61,295,605 shares of common stock, representing a 6.48% stake in the pharmaceutical giant. This filing marks a major increase from a previous reported position of zero, indicating a substantial accumulation of shares. According to the filing, Vanguard Capital Management holds sole dispositive power over all 61,295,605 shares, while maintaining sole voting power over 7,933,831 shares. The reporting person is classified as an Investment Adviser and noted that the securities were acquired in the ordinary course of business without the intent to influence or change the control of the issuer. The reported holdings include shares managed by various affiliates, including Vanguard Asset Management Limited and Vanguard Global Advisers, LLC. The total value of the position is estimated at approximately $57.29 billion based on the provided data.